0

Epoprostenol sodium

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP61849147-A
CAS61849-14-7
Structure
Molecular Weight374.45
InChI KeyOURCVRVJQMLUNA-QFDVFERUSA-M
REAXYS Number6472195
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size100MG
1

Comparative Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Profiles of 3 Different Formulations of Epoprostenol Sodium for Injection in Healthy Men

Laurent B Nicolas, Marcelo M Gutierrez, Jasper Dingemanse

Clin Ther. 2013 Apr;35(4):440-9.

PMID: 23498778

1

Epoprostenol Sodium for Treatment of Pulmonary Arterial Hypertension

Yukihiro Saito, Kazufumi Nakamura, Satoshi Akagi, Toshihiro Sarashina, Kentaro Ejiri, Aya Miura, Aiko Ogawa, Hiromi Matsubara, Hiroshi Ito

Vasc Health Risk Manag. 2015 May 14;11:265-70.

PMID: 25999730

1

Gateways to Clinical Trials

M Bayes, X Rabasseda, J R Prous

Methods Find Exp Clin Pharmacol. 2002 Apr;24(3):159-84.

PMID: 12087878

1

Microbial Challenge Test of a Novel Epoprostenol Sodium Formulation

Dirk Bandilla, Marcel Goverde, Paolo Giudici, Olivier Lambert

Drug Des Devel Ther. 2017 Aug 10;11:2347-2357.

PMID: 28848328

1

Two Formulations of Epoprostenol Sodium in the Treatment of Pulmonary Arterial Hypertension: EPITOME-1 (Epoprostenol for Injection in Pulmonary Arterial Hypertension), a Phase IV, Open-Label, Randomized Study

Kelly M Chin, David B Badesch, Ivan M Robbins, Victor F Tapson, Harold I Palevsky, Nick H Kim, Steven M Kawut, Adaani Frost, Wade W Benton, Jean-Christophe Lemarie, Frederic Bodin, Lewis J Rubin, Vallerie McLaughlin

Am Heart J. 2014 Feb;167(2):218-225.e1.

PMID: 24439983

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode